Skip to main content

Find Clinical Trials

Home
Conditions
Immune Checkpoint Inhibitor-Induced Dermatitis

Clinical trial condition

Immune Checkpoint Inhibitor-Induced Dermatitis

Explore clinical trials studying Immune Checkpoint Inhibitor-Induced Dermatitis. Study availability and eligibility vary by location and protocol.

3 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Immune Checkpoint Inhibitor-Induced Dermatitis trial results

Enrolling by Invitation

Evaluation of Efficacy and Safety of Immune Check Point Inhibitors in Hepatocellular Carcinoma Patients in Ain Shams University Hospitals

NCT07088081

Conditions: Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +14 more
Locations: Ain Shams University Cairo, Abbasya, Egypt

View Trial Details

Not Yet Recruiting

JAK Inhibitors for Solid Malignant Tumor Patients With Refractory Immune Checkpoint Inhibitors-related Dermatitis

NCT07530224

Conditions: Immune Checkpoint Inhibitor-Induced Dermatitis
Locations: Quzhou people's hospital Quzhou, Zhejiang, China

View Trial Details

Completed

SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs

NCT06522048

Conditions: Chemically-Induced Disorders, Dermatitis, Drug Eruptions, +17 more
Locations: First Affiliated Hospital of Fujian Medical University Fuzhou, Fujian, China

View Trial Details